Colgate-Palmolive (NYSE:CL) insider Prabha Parameswaran sold 4,221 shares of Colgate-Palmolive stock in a transaction that occurred on Wednesday, September 11th. The stock was sold at an average price of $71.68, for a total transaction of $302,561.28. Following the completion of the sale, the insider now directly owns 16,793 shares of the company’s stock, valued at approximately $1,203,722.24. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website.

Prabha Parameswaran also recently made the following trade(s):

  • On Thursday, August 8th, Prabha Parameswaran sold 55,835 shares of Colgate-Palmolive stock. The stock was sold at an average price of $70.68, for a total transaction of $3,946,417.80.
  • On Tuesday, August 6th, Prabha Parameswaran sold 5,000 shares of Colgate-Palmolive stock. The stock was sold at an average price of $69.35, for a total transaction of $346,750.00.

Shares of CL stock traded down $1.58 during mid-day trading on Friday, reaching $70.71. 4,669,060 shares of the company’s stock traded hands, compared to its average volume of 3,494,757. Colgate-Palmolive has a 12 month low of $57.41 and a 12 month high of $76.41. The firm has a 50 day moving average price of $72.68 and a two-hundred day moving average price of $70.84. The company has a debt-to-equity ratio of 32.25, a quick ratio of 0.78 and a current ratio of 1.13. The firm has a market capitalization of $61.88 billion, a PE ratio of 23.81, a price-to-earnings-growth ratio of 4.64 and a beta of 0.75.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, July 26th. The company reported $0.72 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.72. Colgate-Palmolive had a net margin of 14.77% and a negative return on equity of 10,821.98%. The firm had revenue of $3.87 billion during the quarter, compared to the consensus estimate of $3.88 billion. During the same quarter in the previous year, the firm posted $0.77 EPS. The company’s revenue for the quarter was down .5% compared to the same quarter last year. As a group, equities analysts expect that Colgate-Palmolive will post 2.84 earnings per share for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Wednesday, October 23rd will be given a dividend of $0.43 per share. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.43%. The ex-dividend date is Tuesday, October 22nd. Colgate-Palmolive’s payout ratio is 57.91%.

Hedge funds have recently modified their holdings of the company. River & Mercantile Asset Management LLP lifted its stake in shares of Colgate-Palmolive by 1.0% during the 2nd quarter. River & Mercantile Asset Management LLP now owns 131,752 shares of the company’s stock valued at $9,437,000 after buying an additional 1,300 shares in the last quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp lifted its stake in shares of Colgate-Palmolive by 14.0% during the 2nd quarter. BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp now owns 369,492 shares of the company’s stock valued at $26,481,000 after buying an additional 45,380 shares in the last quarter. Stonehage Fleming Financial Services Holdings Ltd purchased a new position in shares of Colgate-Palmolive during the 2nd quarter valued at $35,840,000. Rehmann Capital Advisory Group lifted its stake in shares of Colgate-Palmolive by 11.1% during the 2nd quarter. Rehmann Capital Advisory Group now owns 3,160 shares of the company’s stock valued at $227,000 after buying an additional 315 shares in the last quarter. Finally, EP Wealth Advisors LLC purchased a new position in shares of Colgate-Palmolive during the 2nd quarter valued at $1,198,000. 76.64% of the stock is owned by hedge funds and other institutional investors.

CL has been the subject of a number of research analyst reports. Piper Jaffray Companies initiated coverage on shares of Colgate-Palmolive in a research report on Tuesday, August 13th. They issued an “overweight” rating for the company. Wells Fargo & Co lifted their target price on shares of Colgate-Palmolive from $68.00 to $70.00 and gave the stock a “market perform” rating in a research report on Monday, July 29th. Citigroup lifted their target price on shares of Colgate-Palmolive from $77.00 to $79.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 20th. Argus lifted their target price on shares of Colgate-Palmolive from $72.00 to $82.00 and gave the stock a “buy” rating in a research report on Tuesday, June 11th. Finally, ValuEngine downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. One analyst has rated the stock with a sell rating, twelve have given a hold rating and six have issued a buy rating to the company. The company has a consensus rating of “Hold” and an average price target of $73.87.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Story: What is the Gross Domestic Product (GDP)?

Insider Buying and Selling by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.